ERS 2021 International Congress: Benefits of Nasal High Flow therapy in COPD patients in the home

ERS 2021 International Congress: Benefits of Nasal High Flow therapy in COPD patients in the home

ERS 2022: Recent Trial Results for Nasal High Flow on COPD patients at homeПодробнее

ERS 2022: Recent Trial Results for Nasal High Flow on COPD patients at home

High-flow nasal cannula oxygen therapy: An effective treatment option for COPDПодробнее

High-flow nasal cannula oxygen therapy: An effective treatment option for COPD

Nasal high flow at home for COPD patients: a new paradigmПодробнее

Nasal high flow at home for COPD patients: a new paradigm

Outcomes of Nasal High Flow Therapy in Critical CareПодробнее

Outcomes of Nasal High Flow Therapy in Critical Care

Why Aren't You Using High Nasal Flow?Подробнее

Why Aren't You Using High Nasal Flow?

COPD at Home: HFNT or NIV?Подробнее

COPD at Home: HFNT or NIV?

Nasal high‐flow therapy versus NIV in COPD patients with chronic respiratory failureПодробнее

Nasal high‐flow therapy versus NIV in COPD patients with chronic respiratory failure

Nasal High Flow and COPD Focused WebinarПодробнее

Nasal High Flow and COPD Focused Webinar

Experts On Air: High flow nasal cannula - HFOT in hypercapnic respiratory failureПодробнее

Experts On Air: High flow nasal cannula - HFOT in hypercapnic respiratory failure

ERS Congress 2018 Interview: Dave Singh (session highlight)Подробнее

ERS Congress 2018 Interview: Dave Singh (session highlight)

Nasal High Flow Therapy -Implementations in Critical Care and COVID-19Подробнее

Nasal High Flow Therapy -Implementations in Critical Care and COVID-19

High-Flow nasal oxygen therapy device with humidified and heated gas #youtubeshorts #shortsПодробнее

High-Flow nasal oxygen therapy device with humidified and heated gas #youtubeshorts #shorts

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trialПодробнее

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial

Treating the Moderately Dyspneic Patient – Part 2.Подробнее

Treating the Moderately Dyspneic Patient – Part 2.

Nicola A Hanania, ERS 2018 – Biologics in asthma and COPD managementПодробнее

Nicola A Hanania, ERS 2018 – Biologics in asthma and COPD management

Optimising Ventilation and Oxygenation to Protect Vital Organs in COPD and Hypercapnic PatientsПодробнее

Optimising Ventilation and Oxygenation to Protect Vital Organs in COPD and Hypercapnic Patients

Appreciate your doctor. #copd #lungdisease #breathing #lungdisorder #copdaware #respiratorydiseaseПодробнее

Appreciate your doctor. #copd #lungdisease #breathing #lungdisorder #copdaware #respiratorydisease

Nasal High Flow and Exercise in patients with COPDПодробнее

Nasal High Flow and Exercise in patients with COPD